Cite
HARVARD Citation
Turcios, L. et al. (2017). Sorafenib and FH535 in combination act synergistically on hepatocellular carcinoma by targeting cell bioenergetics and mitochondrial function. Digestive and liver disease. 49 (6), pp. 697-704. [Online].